Acceleration of thrombolysis with ultrasound through the cranium in a flow model

Ultrasound Med Biol. 2000 Jun;26(5):889-95. doi: 10.1016/s0301-5629(00)00211-8.

Abstract

Thrombolysis is an efficient therapy for hyperacute stroke within a limited time window. Neurological outcome depends on the recanalization time of the occluded vessel. Nonthermal effects of low-frequency ultrasound (US) accelerate enzymatic fibrinolysis in vitro. We examined the effects of transcranially applied US on recombinant tissue plasminogen activator (rt-PA)-mediated thrombolysis in a flow model in vitro. Pure fibrin clots were placed in a continuous-pressure flow model and treated with rt-PA during 1-MHz US exposure (0.5 W/cm(2); spatial peak, temporal peak intensity). Transcranial and direct US application in combination with rt-PA significantly (p<0.001) shortened recanalization time, increased perfusion flow and reperfusion rate in comparison with rt-PA-mediated thrombolysis alone. Recanalization rate within 30 min was 90-100% in the US-exposed clots vs. 30% in the clots treated only with rt-PA. Our results suggest that transcranial application of 1-MHz US may accelerate reperfusion and recanalization rate of occluded intracerebral vessels by enhancing rt-PA-mediated thrombolysis. Shortening of recanalization time could contribute to optimizing effects of acute thrombolytic stroke therapy.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blood Flow Velocity / drug effects
  • Blood Flow Velocity / physiology
  • Brain Ischemia / diagnostic imaging
  • Brain Ischemia / drug therapy
  • Brain Ischemia / physiopathology*
  • Cerebrovascular Circulation / drug effects
  • Cerebrovascular Circulation / physiology*
  • Humans
  • In Vitro Techniques
  • Models, Biological
  • Phantoms, Imaging
  • Plasminogen Activators / therapeutic use*
  • Recombinant Proteins
  • Thrombolytic Therapy*
  • Tissue Plasminogen Activator / therapeutic use*
  • Ultrasonography, Doppler, Transcranial*

Substances

  • Recombinant Proteins
  • Plasminogen Activators
  • Tissue Plasminogen Activator